Dr B.S. Ajaikumar, Doctorpreneur, Founder and Executive Chairman of HealthCare Global Enterprises Ltd (HCG), has announced the launch of Inviga Healthcare Fund (IHF), a thematic healthcare-focused private equity fund headquartered in Bengaluru. 

Co-founded by Ajay Garg, Founder and Managing Director of Equirus Capital, IHF marks a significant step towards revolutionising the Indian healthcare landscape by enhancing accessibility, affordability and quality of healthcare for all sections of society. Having secured an initial close of $20 million, the fund is poised to empower entrepreneurs and drive meaningful change across the entire Indian healthcare value chain.

Dr Ajaikumar shared his vision for Inviga Healthcare Fund, stating, "Through our investments, we will support the blossoming Indian healthcare entrepreneur ecosystem, foster clinical excellence, focus tenaciously on quality of outcomes, drive deep social impact and help build businesses on sustainable vectors."

In its maiden investment, the Bengaluru-based Inviga Healthcare Fund has announced support for Mynvax, a biotech startup focused on developing novel recombinant vaccines for human respiratory viral diseases, including seasonal influenza and COVID-19. Mynvax is co-founded by Prof. Raghavan Varadarajan and Dr Gautham  Nadig, Professor and alumnus respectively of the Molecular Biophysics Unit at the Indian Institute of Science. 

Inviga will support healthcare and pharmaceutical/life science enterprises throughout the entire value chain, utilising its extensive sector-specific knowledge, global connections, and a distinctive blend of entrepreneurial, clinical, investment, banking, and executive management expertise.